Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

Weitere Gründungsmitglieder sind die European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis und RayzeBio, ein Unternehmen von Bristol Myers Squibb. Wiesbaden, 21. Juni 2025 – Die...
June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

Further founding members include the European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis, and RayzeBio, a Bristol Myers Squibb company. Wiesbaden, June 21, 2025 – The...
February 02, 2024 11:58 ET | Source: KUEHN LAW, PLLC

Kuehn Law Encourages DSKE, RYZB, ROVR, and GRPH Investors to Contact Law Firm

Kuehn Law investigates DSKE, RYZB, ROVR, GRPH mergers for shareholder rights, seeking fair process and disclosures.
December 26, 2023 09:23 ET | Source: Johnson Fistel, LLP

RYZB News: Johnson Fistel Investigates Proposed Sale of RayzeBio; Is $62.50 a Fair Price?

On December 26, 2023, RayzeBio announced that it had entered a deal with Bristol Myers Squibb.
December 26, 2023 07:13 ET | Source: Rayzebio, Inc.

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading Oncology...
November 01, 2023 06:00 ET | Source: Rayzebio, Inc.

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today...